Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
PetMed Express
PETS
$43.4M
| $10.6M | ﹤0.01% |
394,617
+49,226
| +14% | +$1.42M |
|
1977
Clearwater Paper
CLW
$354M
| $10.6M | ﹤0.01% |
275,393
+18,523
| +7% | +$589K |
|
1978
Castle Biosciences
CSTL
$933M
| $10.5M | ﹤0.01% |
158,423
+25,170
| +19% | +$1.77M |
|
1979
NETGEAR
NTGR
$647M
| $10.5M | ﹤0.01% |
330,152
+15,329
| +5% | +$532K |
|
|
LGF.A
1980
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $10.5M | ﹤0.01% |
739,376
+33,069
| +5% | +$484K |
|
1981
Atara Biotherapeutics
ATRA
$76.7M
| $10.5M | ﹤0.01% |
23,381
+177
| +0.8% | +$63.4K |
|
1982
PAR Technology
PAR
$770M
| $10.5M | ﹤0.01% |
169,912
+5,085
| +3% | +$326K |
|
|
DRNA
1983
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $10.4M | ﹤0.01% |
517,263
+17,340
| +3% | +$479K |
|
1984
Zillow
ZG
$8.15B
| $10.4M | ﹤0.01% |
117,516
+5,122
| +5% | +$522K |
|
1985
Smith & Wesson
SWBI
$643M
| $10.4M | ﹤0.01% |
500,555
-33,343
| -6% | -$802K |
|
1986
Inovio Pharmaceuticals
INO
$93M
| $10.4M | ﹤0.01% |
120,890
+1,421
| +1% | +$143K |
|
|
CERE
1987
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $10.4M | ﹤0.01% |
351,808
+100,315
| +40% | +$2.82M |
|
1988
FB Financial Corp
FBK
$3.1B
| $10.4M | ﹤0.01% |
241,800
+10,678
| +5% | +$423K |
|
|
SHYF
1989
DELISTED
The Shyft Group
SHYF
| $10.4M | ﹤0.01% |
272,696
-10,114
| -4% | -$410K |
|
|
BGFV
1990
DELISTED
Big 5 Sporting Goods
BGFV
| $10.3M | ﹤0.01% |
448,490
-306,571
| -41% | -$7.52M |
|
|
JAMF
1991
DELISTED
Jamf
JAMF
| $10.3M | ﹤0.01% |
268,127
+88,467
| +49% | +$3.04M |
|
|
CIVI
1992
DELISTED
Civitas Resources
CIVI
| $10.3M | ﹤0.01% |
215,373
+58,203
| +37% | +$2.38M |
|
1993
International Seaways
INSW
$4.71B
| $10.3M | ﹤0.01% |
565,565
+240,828
| +74% | +$4.11M |
|
1994
Southside Bancshares
SBSI
$984M
| $10.3M | ﹤0.01% |
268,308
+28,037
| +12% | +$1.03M |
|
1995
ALX Oncology
ALXO
$268M
| $10.2M | ﹤0.01% |
138,706
+46,002
| +50% | +$3.07M |
|
1996
Vipshop
VIPS
$6.8B
| $10.2M | ﹤0.01% |
918,915
+73,754
| +9% | +$1.16M |
|
|
GBT
1997
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.2M | ﹤0.01% |
401,677
-22,378
| -5% | -$658K |
|
1998
Marten Transport
MRTN
$1.24B
| $10.2M | ﹤0.01% |
650,480
+29,502
| +5% | +$463K |
|
|
TELL
1999
DELISTED
Tellurian Inc.
TELL
| $10.2M | ﹤0.01% |
2,605,877
+914,134
| +54% | +$3.12M |
|
|
CANO
2000
DELISTED
Cano Health, Inc.
CANO
| $10.2M | ﹤0.01% |
+8,022
| New | +$9.72M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.